Alterations in Brain Transition Metals in Huntington Disease
Authors:
- H. Diana RosasHRH. Diana Rosas
- Y. Iris ChenYCY. Iris Chen
- Gheorghe DorosGDGheorghe Doros
- David H. SalatDSDavid H. Salat
- Nan-Kuei ChenNCNan-Kuei Chen
- Ken K. KwongKKKen K. Kwong
- Ashley BushABAshley Bush
- Jonathan FoxJFJonathan Fox
- Steven M. HerschSHSteven M. Hersch
Open Access
- 1 July 2012
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 69 (7) , 887-893
Abstract
Huntington disease (HD) is a progressive neurodegenerative disorder that causes severe cognitive, motor, and psychiatric disturbances. The genetic basis is an unstable expansion of a triplet repeat that codes for glutamine in the N-terminus of the protein huntingtin, which is widely expressed throughout the body. Transition metals, particularly iron and copper, have been implicated in the pathogenesis of HD. Iron is a potent cause of oxidative damage, which has long been known to accompany neurodegeneration in HD.1 Copper directly catalyzes the oxidation and cysteine cross-linking of huntingtin and may be essential for the oligomerization process that promotes the toxic effects of the mutant protein, while reducing its clearance.2 Evidence has shown that iron and copper concentrations are elevated in the forebrain of HD transgenic mice, and results of human postmortem and magnetic resonance (MR) imaging investigations have demonstrated elevations of iron and copper in the atrophic basal ganglia in symptomatic and advanced HD.3,4 The metal -binding protein clioquinol is neuroprotective in cellular and mouse models of HD, indicating that metal modulation has significant therapeutic potential.5 However, alterations in iron and copper levels, as well as in other transition metals, during the course of HD remain poorly understood.Keywords
This publication has 27 references indexed in Scilit:
- Cysteine Oxidation within N-terminal Mutant Huntingtin Promotes Oligomerization and Delays Clearance of Soluble ProteinJournal of Biological Chemistry, 2011
- SUSCEPTIBILITY-ENHANCED 3-TESLA T1-WEIGHTED SPOILED GRADIENT ECHO OF THE MIDBRAIN NUCLEI FOR GUIDANCE OF DEEP BRAIN STIMULATION IMPLANTATIONNeurosurgery, 2009
- Metal-MACiE: a database of metals involved in biological catalysisBioinformatics, 2009
- Modulation of intracellular iron levels by oxidative stress implicates a novel role for iron in signal transductionBioMetals, 2009
- Complexity and Heterogeneity: What Drives the Ever‐changing Brain in Huntington's Disease?Annals of the New York Academy of Sciences, 2008
- Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneityBrain, 2008
- Mechanisms of Copper Ion Mediated Huntington's Disease ProgressionPLOS ONE, 2007
- An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interestNeuroImage, 2006
- Application of k-space energy spectrum analysis to susceptibility field mapping and distortion correction in gradient-echo EPINeuroImage, 2006
- Thinning of the Cerebral Cortex in AgingCerebral Cortex, 2004